● Recruiting

Study of XmAb412 in Healthy Participants

Condition: Not Applicable - Healthy Adult Participants · Sponsor: Xencor, Inc.

PhasePhase 1

Planned participants128

Who can joinAll sexes, 18 Years to 55 Years

Healthy volunteersYes

About this study

This Phase 1 Study will evaluate the safety, tolerability, pharmacokinectics and pharmacodynamics of XmAb412 in healthy adult participants

This description comes directly from the study's public registry record.

Talk to the study team

412 Study Information · XmAb412-01info@xencor.com

Always discuss trial participation with your own doctor first.

Locations (2)

Xencor Investigative Site	Joondalup, Western Australia, Australia	Recruiting
Xencor Investigative Site	Nedlands, Western Australia, Australia	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07713485